Abstract
Diffuse gliomas encompass a diverse group of tumors of the central nervous system that primarily affect the brain. Patients suffer from a poor prognosis despite radical treatment with surgery, radio- and chemotherapy. Microscopic evaluation by a neuropathologist has been the established method for the clinical diagnosis and determination of follow-up for over a century. Nevertheless, pathology assessment suffers from sampling biases and interobserver variability. This thesis details a number of studies that focus on the molecular analysis of this tumor type. They are a part of a larger series of papers in the past decade that demonstrate that molecular diagnostics can provide an unambiguous diagnosis and determination of follow-up treatment.
Original language | English |
---|---|
Qualification | PhD |
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 15 Sept 2022 |
Place of Publication | s.l. |
Publisher | |
Print ISBNs | 9789464584448 |
Publication status | Published - 15 Sept 2022 |
Keywords
- diffuse glioma
- genomics
- neuropathology
- classification
- sequencing
- DNA methylation
- radiotherapy
- telomere length
- tumor evolution